Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Orthofix Medical Lowers FY2025 Sales Guidance from $818.00M-$826.00M to $808.00M-$816.00M vs $821.98M Est

Author: Benzinga Newsdesk | May 06, 2025 06:14am

Orthofix Medical (NASDAQ:OFIX) lowers FY2025 sales outlook from $818.00 million-$826.00 million to $808.00 million-$816.00 million vs $821.98 million estimate.

Posted In: OFIX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist